Search
Alumis Inc
ALMSAdd to Watchlist
25.310USD
+0.900+3.69%
Close 08-14 16:00（ET）Quotes delayed by 15 min
3.28BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Alumis Inc is 8.91, ranking 37 out of 387 in the Biotechnology & Medical Research industry. The average price target is 18.00, with a high of 25.00 and a low of 14.00.
Analyst Rating
Based on
10
analysts
Strong Buy
Current Rating
40.333
Target Price
+65.23%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Alumis Inc
ALMS
10
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
25
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Alumis Inc's expected revenue for the next quarter?
Alumis Inc's expected revenue is 1.40M.
What is Alumis Inc's price target?
Analysts forecast that Alumis Inc's price target is USD 18.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 14.00.
How have Alumis IncALMS's recent earnings per share performed?
The market expectation was USD -1.11, while Alumis IncALMS's earnings per share (EPS) for the previous quarter was USD -0.74. EPS for the next quarter is expected at USD -0.70.
What is the analyst rating for Alumis Inc?
Based on the ratings of Alumis Inc's stock from 10 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.